Payment overview · 2025
General Payments
$64.92
3 reported records · 1 companies
Healthcare provider profile · identity verified
Yakoub Katri, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · BROOKLYN, NY · NPI 1205049962
Verified facts
What the public records show
CMS Open Payments records show Yakoub Katri, M.D. received $64.92 in general payments during 2025 across 3 reported records.
Neurocrine BioSciences, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $64.92 | 100.0% | 3 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $64.92 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $64.92 | 3 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 559 | 165 |
| Eliquis | Apixaban | 518 | 82 |
| Amlodipine Besylate | Amlodipine Besylate | 327 | 111 |
| Levetiracetam | Levetiracetam | 252 | 63 |
| Metoprolol Tartrate | Metoprolol Tartrate | 244 | 73 |
| Pantoprazole Sodium | Pantoprazole Sodium | 233 | 73 |
| Levothyroxine Sodium | Levothyroxine Sodium | 229 | 71 |
| Tamsulosin Hcl | Tamsulosin Hcl | 222 | 74 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 190 | 52 |
| Furosemide | Furosemide | 188 | 67 |
| Ipratropium Bromide | Ipratropium Bromide | 185 | 40 |
| Gabapentin | Gabapentin | 155 | 50 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 148 | 42 |
| Midodrine Hcl | Midodrine Hcl | 118 | 38 |
| Metoprolol Succinate | Metoprolol Succinate | 116 | 43 |
| Meropenem | Meropenem | 113 | 51 |
| Albuterol Sulfate | Albuterol Sulfate | 112 | 40 |
| Carvedilol | Carvedilol | 112 | 35 |
| Hydralazine Hcl | Hydralazine Hcl | 111 | 37 |
| Losartan Potassium | Losartan Potassium | 110 | 38 |
| Retacrit | Epoetin Alfa-Epbx | 110 | 19 |
| Lacosamide | Lacosamide | 107 | 17 |
| Latanoprost | Latanoprost | 107 | 44 |
| Santyl | Collagenase Clostridium Hist. | 105 | 43 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 102 | 34 |
| Metformin Hcl | Metformin Hcl | 98 | 35 |
| Mirtazapine | Mirtazapine | 98 | 39 |
| Sodium Chloride | 0.9 % Sodium Chloride | 98 | 43 |
| Finasteride | Finasteride | 94 | 30 |
| Sevelamer Carbonate | Sevelamer Carbonate | 94 | 33 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 93 | 14 |
| Sps | Sodium Polystyrene Sulfon/Sorb | 89 | 37 |
| Labetalol Hcl | Labetalol Hcl | 85 | 28 |
| Lisinopril | Lisinopril | 85 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 81 | 24 |
| Nifedipine Er | Nifedipine | 79 | 22 |
| Famotidine | Famotidine | 77 | 31 |
| Procrit | Epoetin Alfa | 73 | 24 |
| Calcium Acetate | Calcium Acetate | 71 | 46 |
| Enoxaparin Sodium | Enoxaparin Sodium | 70 | 13 |
| Lactulose | Lactulose | 69 | 20 |
| Sertraline Hcl | Sertraline Hcl | 69 | 17 |
| Divalproex Sodium | Divalproex Sodium | 65 | 19 |
| Olanzapine | Olanzapine | 65 | 18 |
| Heparin Sodium | Heparin Sodium,porcine | 64 | 22 |
| Amiodarone Hcl | Amiodarone Hcl | 62 | 19 |
| Quetiapine Fumarate | Quetiapine Fumarate | 62 | 16 |
| Trazodone Hcl | Trazodone Hcl | 62 | 20 |
| Velphoro | Sucroferric Oxyhydroxide | 62 | suppressed |
| Omeprazole | Omeprazole | 61 | 42 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 60 | 21 |
| Montelukast Sodium | Montelukast Sodium | 60 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 58 | 13 |
| Januvia | Sitagliptin Phosphate | 57 | 21 |
| Silodosin | Silodosin | 57 | 19 |
| Simvastatin | Simvastatin | 56 | 20 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 54 | 13 |
| Jardiance | Empagliflozin | 54 | 13 |
| Ondansetron Hcl | Ondansetron Hcl | 51 | 17 |
| Silver Sulfadiazine | Silver Sulfadiazine | 51 | 25 |
| Vancomycin Hcl | Vancomycin Hcl | 48 | 25 |
| Brimonidine Tartrate | Brimonidine Tartrate | 46 | 16 |
| Insulin Aspart | Insulin Aspart | 43 | 20 |
| Memantine Hcl | Memantine Hcl | 43 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 42 | 15 |
| Xarelto | Rivaroxaban | 42 | suppressed |
| Aranesp | Darbepoetin Alfa In Polysorbat | 41 | suppressed |
| Glipizide | Glipizide | 41 | 14 |
| Prednisone | Prednisone | 41 | 20 |
| Pregabalin | Pregabalin | 41 | suppressed |
| Insulin Lispro | Insulin Lispro | 40 | 16 |
| Modafinil | Modafinil | 40 | suppressed |
| Nystatin | Nystatin | 40 | 21 |
| Potassium Chloride | Potassium Chloride | 40 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 39 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 38 | 14 |
| Spironolactone | Spironolactone | 38 | 12 |
| Escitalopram Oxalate | Escitalopram Oxalate | 37 | 15 |
| Risperidone | Risperidone | 37 | suppressed |
| Tivicay | Dolutegravir Sodium | 37 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 36 | 17 |
| Amantadine | Amantadine Hcl | 35 | suppressed |
| Budesonide | Budesonide | 33 | 11 |
| Entresto | Sacubitril/Valsartan | 33 | suppressed |
| Ertapenem | Ertapenem Sodium | 33 | 13 |
| Ketoconazole | Ketoconazole | 32 | 14 |
| Metoclopramide Hcl | Metoclopramide Hcl | 32 | suppressed |
| Ssd | Silver Sulfadiazine | 32 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 31 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 30 | suppressed |
| Aripiprazole | Aripiprazole | 29 | suppressed |
| Xcopri | Cenobamate | 29 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 28 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 28 | suppressed |
| Austedo Xr | Deutetrabenazine | 27 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 27 | 12 |
| Novolog | Insulin Aspart | 27 | 11 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 27 | 14 |
| Admelog | Insulin Lispro | 26 | 12 |
| Levofloxacin | Levofloxacin | 26 | 15 |
| Ozempic | Semaglutide | 26 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 26 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 25 | suppressed |
| Isentress | Raltegravir Potassium | 25 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 24 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 23 | 17 |
| Calcitriol | Calcitriol | 23 | 11 |
| Glycopyrrolate | Glycopyrrolate | 23 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 23 | suppressed |
| Mupirocin | Mupirocin | 23 | 11 |
| Topiramate | Topiramate | 23 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 22 | suppressed |
| Cefepime Hcl | Cefepime Hcl | 22 | 13 |
| Ceftriaxone | Ceftriaxone Sodium | 22 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 22 | suppressed |
| Lamotrigine | Lamotrigine | 22 | suppressed |
| Cephalexin | Cephalexin | 21 | 15 |
| Alendronate Sodium | Alendronate Sodium | 20 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 20 | suppressed |
| Metronidazole | Metronidazole | 20 | 17 |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 20 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 20 | suppressed |
| Tradjenta | Linagliptin | 20 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 19 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 18 | suppressed |
| Descovy | Emtricitabine/Tenofov Alafenam | 18 | suppressed |
| Ezetimibe | Ezetimibe | 18 | suppressed |
| Torsemide | Torsemide | 18 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 17 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 17 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 17 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 17 | 12 |
| Renvela | Sevelamer Carbonate | 17 | suppressed |
| Scopolamine | Scopolamine | 17 | suppressed |
| Sucralfate | Sucralfate | 17 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 16 | 16 |
| Alprazolam | Alprazolam | 16 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 16 | suppressed |
| Levemir | Insulin Detemir | 16 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 16 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 15 | suppressed |
| Chlorthalidone | Chlorthalidone | 15 | suppressed |
| Hydrocortisone | Hydrocortisone | 15 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 15 | suppressed |
| Trulicity | Dulaglutide | 15 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 14 | 11 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 14 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 14 | suppressed |
| Darunavir | Darunavir | 14 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 14 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 14 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 13 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 13 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 13 | suppressed |
| Novolin R | Insulin Regular, Human | 13 | suppressed |
| Oxacillin Sodium | Oxacillin Sodium | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Timolol Maleate | Timolol Maleate | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Allopurinol | Allopurinol | 12 | suppressed |
| Clonidine | Clonidine | 12 | suppressed |
| Humalog | Insulin Lispro | 12 | suppressed |
| Pentips Pen Needle | Pen Needle, Diabetic | 12 | 12 |
| Trintellix | Vortioxetine Hydrobromide | 12 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 11 | suppressed |
| Glimepiride | Glimepiride | 11 | suppressed |
| Humulin R | Insulin Regular, Human | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 11 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 11 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 11 | suppressed |
| Ranolazine Er | Ranolazine | 11 | suppressed |
| Vraylar | Cariprazine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $64.92 · 3 records | Neurocrine BioSciences, Inc. | INGREZZA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error